Search for: "Novartis International Pharmaceutical Ltd." Results 21 - 40 of 85
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Mar 2015, 2:43 pm
No muesli mix-up likely in the world where rabbits reignSupreme Petfoods Ltd v Henry Bell & Co (Grantham) Ltd [2015] EWHC 256 (Ch) is another blockbuster judgment from Mr Justice Arnold in the High Court, Chancery Division, England and Wales. [read post]
23 Nov 2007, 9:00 am
You can separately subscribe to the IP Thinktank Global week in Review at [duncanbucknell.com]GlobalReputation and privacy in the online social media world: (IPWar's), McAfee typosquatting study results and implications: (IPWar's),Larry Lessig's comments on how creativity is being strangled by the law: (BLOG@IP::JUR)Two interesting papers on Creative Commons: (CreativeCommons)Friction and 'Warfighting': (IP Think Tank),More on the controversy at WIPO over Kamil Idris'… [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd… [read post]
27 Jan 2021, 11:07 am by anne
Badboy pharmaceutical giant Novartis AG and two of its subsidiaries paid the DOJ and SEC $346.7 million. [read post]
8 Jul 2009, 7:04 am
(Spicy IP) India: Novartis patent rejection by the IPAB: Accessing the decision (Spicy IP) (IAM) India: Likely corruption in the Indian health care sector – Public interest litigation over government shutdown of vaccine production plants to enter contracts with private sector (IP Osgoode) Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch)… [read post]
3 May 2015, 10:33 pm
******************PREVIOUSLY, ON NEVER TOO LATENever too late 42 [week ending on Sunday 26 April] – C5's annual Pharmaceutical Patent Term Extensions Forum | UPC: patent attorney and client discuss | CJEU’s 2014 report | PUMA v PUDEL | Leaked Digital Single Market Strategy | Again of the EU Patent Package  and alleged dangers| EU TM reform | Is Svensson’s new public ok? [read post]
16 Jun 2010, 3:02 pm
Ranbaxy Laboratories Ltd. et al.; Elan Pharma International Ltd. et al. v. [read post]
5 Aug 2009, 7:59 am
EPO - Get your house in order - understand how applications have changed over the last 12 months, and how your company needs to adapt to gain first time patent approval 2009 confirmed speakers include: Bo Hammer Janssen, Senior Patent Counsel, Novozymes Nicolas Ruiz, Head of IP, Esteve Dr Mandar Kodgule, Head, Intellectual Property and Strategic Planning, Wockhardt Ltd Dr William Heggie, CSO, Hovione James Horgan, Assistant Counsel, Merck, Sharpe & Dohme Ltd Dr… [read post]
27 Feb 2009, 5:00 am
USA, Inc (Orange Book Blog) (FDA Law Blog) (Patent Baristas) (Law360) (Patent Docs) (Patent Prospector) (Patently-O) (GenericsWeb) (Hal Wegner) Famvir (Famciclovir) – US: Teva loses bid to toss Novartis wilful infringement claims over Famvir (Law360) Fentora (Fentanyl) – US: Barr alleges Cima and Cephalon’s patent suit just a delay tactic (Law360) Integrilin (Eptifibatide) – US: Schering alleges patent infringement following Teva’s Para IV… [read post]
25 May 2015, 4:15 am
  The parties have been back in court to fight over other patents, resulting in the decision Synthon B.V. v Teva Pharmaceutical Industries Ltd [2015] EWHC 1395 (Pat), which came out last week and which Darren reports in timely fashion.* When functionality cuts deep, it can be hard to handle: Yoshida appeal dismissedValentina's back again to pen on General Court's decision in Joined Cases C‑337/12 P to C‑340/12 P Pi-Design AG,… [read post]
1 Dec 2010, 10:00 pm by Rosalind English
The first point to make is that the product at the centre of all this soul searching product itself is not manufactured in the UK; it is produced in Austria as part of the Novartis pharmaceutical group. [read post]
8 Dec 2007, 11:00 am
: (IP Think Tank), WIPO - Idris gets paid out to leave early: (IAM), (Patent Prospector), Deutsche Grammophon ditches DRM: (ArsTechnica)PharmaFDA revisits NCE exclusivity for enantiomers: (Arnall Golden & Gregory), Accupril (Quinapril) - Judge finds against Teva and holds Warner-Lambert patent enabled: (IPLaw360), (OrangeBookBlog), Altace / Tritace / Ramace (Ramipril) - King Pharmaceuticals loses CAFC rehearing bid: (IPLaw360), … [read post]
8 Dec 2010, 1:49 am
No more partying for Novartis. [read post]